Skip to main content

Figure 2 .

Figure 2

(A) A comparison of TNFα and CRP levels over the first six months of treatment with infliximab in responders. Response to treatment was defined using the ASAS 20 response criteria as before. (B) A comparison of TNFα and CRP levels in non-responders over the first six months of treatment with infliximab. Response to treatment was defined using the ASAS 20 response criteria as before.